https://pharminent.com/oncology/oncology-intelligence-digest-september-4-2026/ 2026-09-05T21:19:27Z Pharminent en Oncology Intelligence Digest • September 4, 2026 2026-09-05T21:19:24Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-september-4-2026/ 2026-09-05T21:08:49Z Pharminent en GLP-1 Competitive Market Digest • Weekly • September 4, 2026 2026-09-05T21:08:47Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-september-4-2026/ 2026-09-05T20:56:00Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • September 4, 2026 2026-09-05T20:55:58Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-september-3-2026/ 2026-09-04T22:02:35Z Pharminent en Rare Disease & Gene Therapy Digest • September 3, 2026 2026-09-04T22:02:32Z Blog https://pharminent.com/ionis-wins-first-ever-fda-approval-for-alexander-disease-with-zanvastro/ 2026-09-04T20:32:20Z Pharminent en Ionis Wins First-Ever FDA Approval for Alexander Disease with Zanvastro 2026-09-04T20:32:16Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-4-2026/ 2026-09-04T18:19:34Z Pharminent en Strategic News Watch • September 4, 2026 2026-09-04T18:07:39Z Blog https://pharminent.com/ivonescimab-beats-keytruda-on-survival-in-china-only-trial-as-its-global-study-stumbles/ 2026-09-03T20:06:24Z Pharminent en Ivonescimab Beats Keytruda on Survival in China-Only Trial as Its Global Study Stumbles 2026-09-03T20:06:21Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-3-2026/ 2026-09-03T17:11:06Z Pharminent en Strategic News Watch • September 3, 2026 2026-09-03T17:11:04Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-september-2-2026/ 2026-09-03T17:03:46Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • September 2, 2026 2026-09-03T17:03:43Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-september-2-2026/ 2026-09-03T17:00:44Z Pharminent en Manufacturing Intelligence • Weekly Digest • September 2, 2026 2026-09-03T17:00:42Z Blog https://pharminent.com/boehringer-signs-ai-drug-discovery-deal-with-owkin/ 2026-09-03T18:50:29Z Pharminent en Boehringer signs AI drug discovery deal with Owkin 2026-09-03T09:12:00Z Blog https://pharminent.com/novartis-signs-3-2bn-drug-delivery-deal-with-alteogen/ 2026-09-03T18:50:17Z Pharminent en Novartis signs $3.2bn drug delivery deal with Alteogen 2026-09-03T08:37:52Z Blog